MAZ promotes tumor proliferation and immune evasion in lung ...
19 hours ago · Global cancer statistics have shown that lung cancer remains the leading cause of cancer-related deaths [].Among all patients with lung cancer, more than 40% have lung adenocarcinoma (LUAD), which ...
Lung Cancer News -- ScienceDaily
2 days ago · Information about lung cancer symptoms and treatments. Explore the latest medical research on cancers including experimental treatments.
Lung cancer survival rates are up thanks to immunotherapy, other ... - NPR
Apr 12, 2024 · Lung cancer remains the most lethal form of the disease, killing about 135,000 Americans a year – more than breast, prostate and colon cancer combined – which is why many people still think of...
‘Amazing’ trial shows drug combination stops lung cancer ... - UCL
Oct 7, 2024 · “Better understanding of the biology that drives lung cancers has guided the development of these targeted therapies,” said Dr Martin Forster (UCL Research Department of Oncology) on his team’s newly developed treatment for lung cancer.
Lung cancer - Latest research and news | Nature
Sep 18, 2024 · Lung cancer articles from across Nature Portfolio. Lung cancer arises in tissues of the lung, usually in the cells lining air passages. The two main types are small-cell lung cancer and...
Targeted Drug Stops Lung Cancer Growth for Five Years in Over …
Jun 13, 2024 · A study shows that a targeted therapy drug stops the spread of lung cancer for 5 years or more. The drug, lorlatinib (Lobrena), also stops new cancer growth in the brain. These benefits were seen in 3 out of every 5 people with advanced non-small cell lung cancer (NSCLC) with an ALK gene mutation.
Lung cancer treatment produces progression-free survival results …
Jun 5, 2024 · The positive results from the LAURA Phase III trial underscore the importance of early testing and diagnosis in lung cancer, which remains the leading cause of cancer death worldwide,...
Lung cancer treatment: Pfizer's Lorbrena extends life in ... - NBC News
May 31, 2024 · Pfizer’s lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for years longer than other drugs, according to new research published Friday. The drug treats a...
FDA Approves New Drug for Deadly Lung Cancer - U.S. News
FRIDAY, May, 17, 2024 (HealthDay News) -- The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer.
Osimertinib Improves Survival in Lung Cancer - NCI
Jul 5, 2023 · Improved overall survival with osimertinib. The initial results from ADAURA, published in October 2020, offered signs of possible survival improvements with adjuvant osimertinib. This treatment, they showed, dramatically improved how long people lived without any evidence of their cancer returning.